AEGiS-PRn: Bush AIDS Plan Reaches 1.25% of Treatment Goal PRNewswireImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to PRNewswire main menu
DonateNow
Print this article

Bush AIDS Plan Reaches 1.25% of Treatment Goal

PRNewswire - September 14, 2004


WASHINGTON, Sept. 14 /PRNewswire/ -- Global AIDS Alliance reacted today to the statement of the Bush Administration regarding its global AIDS programs.

The Administration says it is providing AIDS treatment to 25,000 people through its own programs as well as its contributions to other AIDS programs. This figure represents 1.25% of the goal the Administration announced in January 2003, which was to deliver treatment to 2 million people by 2008.

The Bush plan is using expensive, brand name drugs, rather than keeping its promise to use the lowest cost drugs available. The President's promised "expedited" approval process has yet to review a single generic drug for use in the US program.

"It's disappointing that a year and a half after declaring AIDS a global emergency, we are still just 1.25% towards the treatment goal that had been announced," stated Dr. Paul Zeitz, Executive Director of Global AIDS Alliance. "If the Administration had not rejected emergency funding of its initiative last year we would certainly be further along."

The US Congress, in its AIDS authorization bill passed last year, set a goal of 500,000 people on treatment by September 30, 2004. The Administration's performance represents 5% of what Congress had called for at this stage.

Meanwhile, the Administration has undermined the progress of the Global Fund, a multilateral effort delivering resources for AIDS medication to a much broader list of countries. The President has proposed cutting the US contribution to the Fund for 2005 by 64% and done little to convince close allies like Japan and South Korea to give their fair share. The Administration's Global AIDS Coordinator recently said the Fund already had "adequate resources on hand," even though the Fund is so short of available resources that it will likely not be able to issue new grants until 2007. At its November meeting the Fund is expected to cancel the additional grantmaking that had been planned for next year.

The President has also taken steps to curtail competition from low-cost generic medications, even though they are successfully used around the world. Strong-arm tactics by the Administration have already resulted in agreements by many Latin American countries, as well as Morocco and Singapore, to block generics. Thailand, an innovator in the production of AIDS medication, is now under severe pressure to follow suit.

SOURCE Global AIDS Alliance

Web Site: http://www.globalaidsalliance.org


040914
PR040918


Copyright © 2004 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019  http://www.prnewswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .